Search
for
Sort by
Research 61–90 of 644
- Cardiovascular risk factors and events in women with androgen excess
- Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
- AMALAKI (EMBLICA OFFICINALIS GAERTN.): AN INTEGRATIVE REVIEW AND META-ANALYSIS OF CLASSICAL AYURVEDIC PERSPECTIVES AND MODERN CLINICAL EVIDENCE
- Un asentamiento de la primera Edad del Hierro en el término de Raposal (Arnedo, La Rioja)
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Comorbidities in Discoid Lupus: A Systematic Review and Meta-analysis of Prevalence and Association
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Relationship Between Steroid Hormones and Metabolic Profile in Women With Polycystic Ovary Syndrome
- Collagen, Diet, and Lifestyle Disorders: Interactions Across Metabolic, Cardiovascular, Skin, Joint, and Gut Health
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks
- 73323 Androgenic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
- Exercise in the management of polycystic ovary syndrome: A position statement from Exercise and Sports Science Australia
- POLY CYSTIC OVARIAN SYNDROME: AN UPDATED REVIEW
- Androgenetic alopecia is not associated with increased incidence of cardiovascular disease risk factors: A retrospective cohort study
- Why cells need iron: a compendium of iron utilisation
- Assessment, diagnosis and treatment of a patient with hirsutism
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- Serum irisin and insulin resistance in patients with early-onset androgenetic alopecia: a case-control study
- From male PCOS to male endocrine-metabolic syndrome: a gender-neutral hypothesis
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- NAD⁺ Biology in Ageing and Chronic Disease: Mechanisms and Evidence across Skin, Fertility, Osteoarthritis, Hearing and Vision Loss, Gut Health, Cardiovascular–Hepatic Metabolism, Neurological Disorders, and Muscle
- Metabolic aging and cutaneous markers of metabolic syndrome: a narrative review